Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A major side effect of this class of drugs is rapid weight loss
Tirzepatide can be a great option for people who did not respond to or tolerate side-effects from previous weight-loss medications or who have plateaued on their current weight-loss routine
As of mid-2025, retatrutide remains in clinical trials and has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)
Complete an online intake form, and discover if a weight loss medication covered by your insurance is your next step
prescribing information, revised in December 2025, integrates these indications for both injection and tablet formulations, while incorporating updated guidance on severe gastrointestinal events, acute kidney injury, and periprocedural aspiration risk
US$ 28.29
US$ 27.30
US$ 23.15
&srotate=0)
US$ 28.84
